Organization · Family Office
Byers Capital
Byers Capital is a single family office that focuses on direct investments in technology and biotechnology companies, participating in various investment stages including seed and growth rounds.
Overview
What Byers Capital does
What Byers Capital is
Byers Capital is a single family office that focuses on direct investments in technology and biotechnology companies, participating in various investment stages including seed and growth rounds.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Family Office
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Byers Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Byers Capital as a funder
Investment thesis
Byers Capital invests primarily in technology and biotechnology sectors, engaging in various stages of investment including seed, Series A, and growth rounds.
Focus narrative
Byers Capital invests primarily in technology and biotechnology sectors. The organization engages in various stages of investment, including seed, Series A, and growth rounds.
Focus and fit
- Stages
- Seed · Series A · Growth Equity
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 10
Portfolio context
Notable portfolio companies include: Neuralink - Series B investment in brain-computer interfaces, co-founded by Elon Musk. NewLimit - Series A investment focused on longevity, co-founded by Brian Armstrong, Jacob Kimmel, and a member of Byers Capital. Factory - Seed investment in AI coding agents, co-founded by Matan Grinberg. SpaceX - Growth investment made in 2018, aimed at enabling multi-planetary human existence, co-founded by Elon Musk. Xai - Series A investment focused on understanding the universe, co-founded by Elon Musk. Harmonic - Series A investment in mathematical superintelligence, co-founded by Vlad Tenev. Vial - Series A investment in clinical drug development at scale, co-founded by Simon Burns. Xaira - Series A investment in AI drug discovery, co-founded by Marc Tessier-Lavigne. Chai Discovery - Series A investment in in silico drug creation, co-founded by Jack Dent and Joshua Meier. The Bot Co - Seed investment in AI-powered robots for home use, co-founded by Kyle Vogt.
Common questions
What to know about Byers Capital
Upseed classifies Byers Capital under the Family Office organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.